Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab

Diagn Interv Imaging. 2020 May;101(5):323-324. doi: 10.1016/j.diii.2020.03.010. Epub 2020 Mar 31.

Authors

M Cellina¹, M Orsi², F Bombaci², M Sala³, P Marino³, G Oliva²

Affiliations

¹ Department of Radiology, Ospedale Fatebenefratelli, ASST Fatebenefratelli Sacco, 20121 Milan, Italy. Electronic address: michaela.cellina@asst-fbf-sacco.it.
² Department of Radiology, Ospedale Fatebenefratelli, ASST Fatebenefratelli Sacco, 20121 Milan, Italy.
³ Emergency Department, Ospedale Fatebenefratelli, ASST Fatebenefratelli Sacco, 20121 Milan, Italy.

No abstract available

Keywords: COVID-19; Computed tomography; Coronavirus; Pneumonia; Severe acute respiratory syndrome coronavirus 2; Viral.

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Betacoronavirus*
COVID-19
Coronavirus Infections
Humans
Pandemics
Pneumonia, Viral
SARS-CoV-2
Tomography, X-Ray Computed

Substances

Antibodies, Monoclonal, Humanized
tocilizumab